These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35142188)

  • 21. [Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors].
    Xu LW; Wei XL; Wei YQ; Hao XX; Zhou QJ; Feng R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):30-5. PubMed ID: 26913389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review.
    Hasan H; Shaikh OM; Rassekh SR; Howard AF; Goddard K
    Pediatr Blood Cancer; 2017 Jan; 64(1):81-88. PubMed ID: 27578304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the Effectiveness and Safety of Combined Chemotherapy with PEG-Asp for Treatment of ALL and T-NHL Patients].
    Xu Y; Wang J; Yang N; Bai J; Zhang PY; Gu LF; Lei B; Liu J; Wang FX; Huang BQ; Zhang WG; He AL; Cao XM; Chen YX; Ma XR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):405-10. PubMed ID: 27151000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
    Buie LW; Moore J; van Deventer H
    Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study.
    Silva WFD; Massaut IHB; Bendlin RM; Rosa LI; Velloso EDRP; Rego EM; Rocha V
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e523-e528. PubMed ID: 32389674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
    Sahiner UM; Yavuz ST; Gökce M; Buyuktiryaki B; Altan I; Aytac S; Tuncer M; Tuncer A; Sackesen C
    Pediatr Int; 2013 Aug; 55(4):531-3. PubMed ID: 23910807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
    Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial.
    Escherich G; Zur Stadt U; Zimmermann M; Horstmann MA;
    Br J Haematol; 2013 Oct; 163(2):240-7. PubMed ID: 23937310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia.
    Chen J; Ngo D; Aldoss I; Shayani S; Tsai NC; Pullarkat V
    Leuk Lymphoma; 2019 May; 60(5):1187-1192. PubMed ID: 30322332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
    Ettinger LJ; Kurtzberg J; Voûte PA; Jürgens H; Halpern SL
    Cancer; 1995 Mar; 75(5):1176-81. PubMed ID: 7850718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients.
    Wu J; Chen C; Huang S; Shen S; Chen J; Zhang S
    Technol Cancer Res Treat; 2020; 19():1533033820980113. PubMed ID: 33287663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
    Lee JH; Lee J; Yhim HY; Oh D; Bang SM
    J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Derman BA; Streck M; Wynne J; Christ TN; Curran E; Stock W; Knoebel RW
    Leuk Lymphoma; 2020 Mar; 61(3):614-622. PubMed ID: 31680584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
    Ishihara T; Nogami K; Ochi S; Ishida T; Kosaka Y; Sawada A; Inoue M; Osone S; Imamura T; Hosoi H; Shima M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28016. PubMed ID: 31556233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
    Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
    Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
    Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.